Q2 2024 Report: China's Probiotics E-Commerce Market Trends

Key Finding 1

China's Taobao (淘宝) and Tmall (天猫) probiotics market recorded CN¥ 1.92B in Q1 2024 sales, a -13.8% YoY decline, as consumer penetration remains low and the broader domestic spending environment pressured growth across all major categories.

The probiotics market on Taobao-Tmall platforms experienced a meaningful contraction in Q1 2024. Total sales reached CN¥ 1.92B with 808.2M units sold, representing a -13.8% YoY decline in revenue. Tmall (天猫) remained the dominant channel, commanding over 80% of total sales value, while Taobao (淘宝) contributed just 18.0%. The slowdown reflects two converging forces: the proliferation of probiotics ingredients across food, beverage, and personal care categories has intensified competition and fragmented demand, while the broader macroeconomic environment has made consumers more cautious in their spending. Despite the current downturn, the lifetime demand for probiotics across all age groups continues to present significant long-term market opportunity.

Key Finding 2

Probiotics health supplements accounted for 41.0% of the total probiotics market in Q1 2024 at CN¥ 790M, followed by dairy products at 36.9% (CN¥ 710M) and other categories at 22.0% (CN¥ 420M) -- all three segments posted negative YoY growth, with health supplements falling the hardest at -27.0%.

The market structure reveals a bifurcated landscape. Health supplements remain the largest category by revenue, but their -27.0% YoY decline signals a maturing segment where brand consolidation is accelerating and new entrant activity is intensifying price competition. Dairy products showed greater resilience at just -0.9% YoY decline, supported by the stable everyday consumption pattern of probiotic milk powder, yoghurt, and fermented beverages. The "other" probiotics category -- primarily personal care products such as toothpaste, mouthwash, and skincare -- declined -2.3% YoY but demonstrated a notable structural shift: the washing and cleaning sub-segment grew its share from 54.1% to 66.3%, posting +19.8% YoY growth.

Key Finding 3

While traditional probiotics categories contracted, three emerging functional segments posted strong positive growth in Q1 2024: adjuvant therapy probiotics (+101.9% YoY), oral health probiotics (+80.2% YoY), and mood regulation probiotics (+64.1% YoY), collectively signalling a shift toward specialised, condition-specific products.

The most significant structural trend within the probiotics health supplements market is the divergence between established and emerging functional segments. Gut health probiotics, the dominant sub-category at 55.9% market share, declined -35.5% YoY to CN¥ 441.1M. Immune regulation probiotics (10.6% share) fell -7.7% YoY, and women's intimate care probiotics (6.8% share) dropped -23.6% YoY. In contrast, the three fastest-growing segments -- adjuvant therapy, oral health, and mood regulation -- all surpassed +50% YoY growth. Adjuvant therapy probiotics, targeting IBS and inflammatory bowel conditions, more than doubled revenue to CN¥ 6.69M. These emerging segments remain small in absolute terms but represent the frontier of consumer demand evolution, driven by growing health literacy, social media education, and brands' investment in condition-specific product positioning.